Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.78 USD
Change Today +0.04 / 1.07%
Volume 3.0M
As of 8:04 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sergio Traversa PharmD, MBA

AgeTotal Calculated CompensationThis person is connected to 24 board members in 3 different organizations across 4 different industries.

See Board Relationships


Dr. Sergio Traversa, PharmD, MBA has been the Chief Executive Officer at Relmada Therapeutics, Inc. since April 18, 2012. Dr. Traversa has over twenty-five years of experience in the healthcare sector in the United States and Europe, ranging from management positions in the pharmaceutical industry to investing and strategic advisory roles. Dr. Traversa served as the Interim Chief Financial Officer of Actinium Pharmaceuticals, Inc. since March 11, 2013 and also served ...

Read Full Background

Corporate Headquarters*

546 Fifth Avenue
New York, New York 10036

United States

Phone: 646-459-4201
Fax: --

Board Members Memberships*

Chief Executive Officer and Director


New York University - Leonard N. Stern School of Business
Unknown/Other Education
Universita' degli Studi di Torino

Other Affiliations*

Annual Compensation*

Total Annual Compensation$182,501

Stock Options*

Exercisable Options652,005
Unexercisable Options691,707
Total Number of Options1,343,712

Total Compensation*

Total Annual Cash Compensation$182,501
Total Short Term Compensation$182,501
Total Calculated Compensation$182,501
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATNM:US $3.78 USD +0.04


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTINIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at